Literature DB >> 28535125

Preparation and characterization of adefovir dipivoxil-stearic acid cocrystal with enhanced physicochemical properties.

Jeong-Woong Seo1, Kyu-Min Hwang1, Sung-Hoon Lee2, Dong-Wook Kim2, Eun-Seok Park1.   

Abstract

The objectives of this study were to prepare cocrystal composed of adefovir dipivoxil (AD) and stearic acid (SA) and to investigate the enhanced properties of the cocrystal. The cocrystal was prepared by antisolvent precipitation and characterized by scanning electron microscopy (SEM), Fourier transform infrared spectroscopy (FT-IR), X-ray powder diffraction (XRPD), and differential scanning calorimetry (DSC). The enhanced properties were evaluated by dissolution testing, permeability studies, and powder rheology analysis. The AD raw material has a cuboid-like crystal and the cocrystal has a needle shape. In the FT-IR study, there were bathochromic shifts caused by the hydrogen bonding. The melting point of the cocrystal was 52.9 °C, which was lower than that of AD. The XRPD pattern also had distinct differences, supporting the formation of a new crystalline form. The cocrystal showed changes in the lattice energy and the solvation strength, which caused an enhanced dissolution. The permeability was increased due to the SA, which acts as a P-gp inhibitor. The tabletability was enhanced due to the altered crystal habit. In conclusion, cocrystal containing AD and SA was successfully prepared, presenting advantages such as enhanced solubility, tabletability, and permeability. The use of the cocrystal is a desirable approach for the improved physicochemical properties.

Entities:  

Keywords:  Cocrystal; adefovir dipivoxil; dissolution rate; permeability; tabletabilty

Mesh:

Substances:

Year:  2017        PMID: 28535125     DOI: 10.1080/10837450.2017.1334664

Source DB:  PubMed          Journal:  Pharm Dev Technol        ISSN: 1083-7450            Impact factor:   3.133


  5 in total

Review 1.  Engineering Cocrystals of PoorlyWater-Soluble Drugs to Enhance Dissolution in Aqueous Medium.

Authors:  Indumathi Sathisaran; Sameer Vishvanath Dalvi
Journal:  Pharmaceutics       Date:  2018-07-31       Impact factor: 6.321

2.  Preparation, characterization, and pharmacokinetics of rivaroxaban cocrystals with enhanced in vitro and in vivo properties in beagle dogs.

Authors:  Yuanyuan Meng; Fangyun Tan; Jiaxin Yao; Yanan Cui; Yumiao Feng; Zhiping Li; Yuli Wang; Yang Yang; Wei Gong; Meiyan Yang; Xiaolong Kong; Chunsheng Gao
Journal:  Int J Pharm X       Date:  2022-05-21

3.  Superior Dissolution Behavior and Bioavailability of Pharmaceutical Cocrystals and Recent Regulatory Issues.

Authors:  Meng Y Xia; Bing Q Zhu; Jian-R Wang; Ze E Yang; Xue F Mei
Journal:  ACS Med Chem Lett       Date:  2021-12-30       Impact factor: 4.345

Review 4.  Recent advances in improving oral drug bioavailability by cocrystals.

Authors:  Shahram Emami; Mohammadreza Siahi-Shadbad; Khosro Adibkia; Mohammad Barzegar-Jalali
Journal:  Bioimpacts       Date:  2018-05-31

5.  Physicochemical and pharmacological evaluation of carvedilol-eudragit® RS100 electrosprayed nanostructures.

Authors:  Sevil Selselehjonban; Alireza Garjani; Karim Osouli-Bostanabad; Ali Tanhaei; Shahram Emami; Khosro Adibkia; Mohammad Barzegar-Jalali
Journal:  Iran J Basic Med Sci       Date:  2019-05       Impact factor: 2.699

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.